Register entry
Excella GmbH & Co. KG
- Registered sites
- 1
- Drug products
- 73
- Live patents
- 0
- Countries
- 1
- Base
- Germany
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Excella GmbH & Co. KG | FeuchtGermany | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 3000242652 |
Catalogue
Marketed products
73Showing 73 of 73.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | ALECTINIB HYDROCHLORIDE | CAPSULE | DRUG FOR FURTHER PROCESSING |
| - | Acyclovir Sodium | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Adapalene | POWDER | BULK INGREDIENT |
| - | Anastrozole | POWDER | BULK INGREDIENT |
| - | Anastrozole | POWDER | BULK INGREDIENT |
| - | Anastrozole | POWDER | BULK INGREDIENT |
| - | Baclofen | POWDER | BULK INGREDIENT |
| - | Baclofen | POWDER | BULK INGREDIENT |
| - | Baclofen(R) | POWDER | BULK INGREDIENT |
| - | Bicalutamide | POWDER | BULK INGREDIENT |
| - | Bicalutaminde milled | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Bupivacaine Hydrochloride monohydrate | POWDER | BULK INGREDIENT |
| - | Buspirone HCl | POWDER | BULK INGREDIENT |
| - | Buspirone Hydrochloride sieved | POWDER | BULK INGREDIENT |
| - | Cevimeline Hydrochloride | POWDER | BULK INGREDIENT |
| - | Clomiphene citrate | POWDER | BULK INGREDIENT |
| - | Deferoxamine mesylate | POWDER | BULK INGREDIENT |
| - | Deferoxamine mesylate | POWDER | BULK INGREDIENT |
| - | Deracoxib | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Deracoxib milled | POWDER | BULK INGREDIENT |
| - | Doxazosin mesylate | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | EMTRICITABINE | CAPSULE | DRUG FOR FURTHER PROCESSING |
| - | Eplerenone | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Firocoxib | POWDER | BULK INGREDIENT |
| - | Firocoxib | POWDER | BULK INGREDIENT |
| - | Ganciclovir Sodium | INJECTION | BULK INGREDIENT |
| - | Haloperidol | POWDER | BULK INGREDIENT |
| - | Lanthanum Carbonate Hydrated | POWDER | BULK INGREDIENT |
| - | Levothroxine sodium | POWDER | BULK INGREDIENT |
| - | Levothyroxine Sodium | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Methotrexate | POWDER | BULK INGREDIENT |
| - | Methotrexate | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Methotrexate | POWDER | BULK INGREDIENT |
| - | Methotrexate Disodium | POWDER | BULK INGREDIENT |
| - | Methotrexate Disodium Salt | POWDER | BULK INGREDIENT |
| - | Mycophenolate Mofetil | POWDER | BULK INGREDIENT |
| - | Paroxetine Mesylate | POWDER | BULK INGREDIENT |
| - | Paroxetine Mesylate | POWDER | BULK INGREDIENT |
| - | Pirenzepine Monohydrate | POWDER | BULK INGREDIENT |
| - | Relugolix | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Ropivacaine Hydrochloride | INJECTION, SOLUTION | BULK INGREDIENT |
| - | Ropivacaine hydrochloride | INJECTION, SOLUTION | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Selexipag | CAPSULE | DRUG FOR FURTHER PROCESSING |
| - | Selexipag | CAPSULE | DRUG FOR FURTHER PROCESSING |
| - | Selexipag | CAPSULE | DRUG FOR FURTHER PROCESSING |
| - | Selexipag | KIT | DRUG FOR FURTHER PROCESSING |
| - | TRYVIO | CAPSULE | DRUG FOR FURTHER PROCESSING |
| - | Talazoparib | POWDER | BULK INGREDIENT |
| - | Tamoxifen Citrate | POWDER | BULK INGREDIENT |
| - | Tamoxifen Citrate | POWDER | BULK INGREDIENT |
| - | Tamoxifen citrate | POWDER | BULK INGREDIENT |
| - | Tamoxifen citrate | POWDER | BULK INGREDIENT |
| - | Temozolomide | POWDER | BULK INGREDIENT |
| - | Temozolomide | POWDER | BULK INGREDIENT |
| - | Temozolomide | POWDER | BULK INGREDIENT |
| - | Timolol maleate | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Timolol maleate | POWDER | BULK INGREDIENT |
| - | Timolol(S)Base Hemihydrate | POWDER | BULK INGREDIENT |
| - | UPTRAVI | CAPSULE | DRUG FOR FURTHER PROCESSING |
| - | UPTRAVI | CAPSULE | DRUG FOR FURTHER PROCESSING |
| - | UPTRAVI | CAPSULE | DRUG FOR FURTHER PROCESSING |
| - | UPTRAVI | CAPSULE | DRUG FOR FURTHER PROCESSING |
| - | UPTRAVI | CAPSULE | DRUG FOR FURTHER PROCESSING |
| - | UPTRAVI | CAPSULE | DRUG FOR FURTHER PROCESSING |
| - | azacitidine | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | azacitidine | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | busulfan | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | capecitabine | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | chlorambucil | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | macitentan | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | neratinib | TABLET | DRUG FOR FURTHER PROCESSING |
| - | paroxetine | CAPSULE | DRUG FOR FURTHER PROCESSING |
| - | thioguanine | TABLET | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.